169 related articles for article (PubMed ID: 25319380)
1. Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy.
Alexandrakis I; Tuli R; Ractliffe SC; Tappin SW; Foale RD; Roos A; Slater KJ
Vet Comp Oncol; 2017 Mar; 15(1):6-17. PubMed ID: 25319380
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study.
Baskin CR; Couto CG; Wittum TE
J Am Anim Hosp Assoc; 2000; 36(5):404-9. PubMed ID: 10997515
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
Wang SL; Lee JJ; Liao AT
Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy.
Merlo A; Rezende BC; Franchini ML; Simões DM; Lucas SR
J Am Vet Med Assoc; 2007 Feb; 230(4):522-6. PubMed ID: 17302548
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.
Van Vechten M; Helfand SC; Jeglum KA
J Vet Intern Med; 1990; 4(4):187-91. PubMed ID: 2401965
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs.
Merlo A; Rezende BC; Franchini ML; Monteiro PR; Lucas SR
Vet Clin Pathol; 2008 Mar; 37(1):79-85. PubMed ID: 18366549
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma.
Winter JL; Barber LG; Freeman L; Griessmayr PC; Milbury PE; Blumberg JB
J Vet Intern Med; 2009; 23(2):311-6. PubMed ID: 19210312
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.
Meyer A; Eberle N; Bullerdiek J; Nolte I; Simon D
Vet Comp Oncol; 2010 Jun; 8(2):127-37. PubMed ID: 20579326
[TBL] [Abstract][Full Text] [Related]
10. Increase in minimal residual disease in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy.
Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
J Vet Intern Med; 2011; 25(2):292-6. PubMed ID: 21314721
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma.
Keller ET; MacEwen EG; Rosenthal RC; Helfand SC; Fox LE
J Vet Intern Med; 1993; 7(5):289-95. PubMed ID: 8263847
[TBL] [Abstract][Full Text] [Related]
12. Vinblastine as a second rescue for the treatment of canine multicentric lymphoma in 39 cases (2005 to 2014).
Lenz JA; Robat CS; Stein TJ
J Small Anim Pract; 2016 Aug; 57(8):429-34. PubMed ID: 27251593
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.
Siedlecki CT; Kass PH; Jakubiak MJ; Dank G; Lyons J; Kent MS
Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229
[TBL] [Abstract][Full Text] [Related]
14. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Gray KN; Raulston GL; Gleiser CA; Jardine JH
J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant human interferon alpha-2a in the management of a dog with epitheliotropic lymphoma.
Tzannes S; Ibarrola P; Batchelor DJ; Burrow RD; Blackwood L
J Am Anim Hosp Assoc; 2008; 44(5):276-82. PubMed ID: 18762565
[TBL] [Abstract][Full Text] [Related]
16. Multicentric canine lymphoma in a 12-year-old keeshond: chemotherapy options.
Martineau MM
Can Vet J; 2002 Sep; 43(9):709-11. PubMed ID: 12240530
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy in the treatment of canine lymphoma.
Mayer MN; Larue SM
Can Vet J; 2005 Sep; 46(9):842-4. PubMed ID: 16231659
[No Abstract] [Full Text] [Related]
18. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
[TBL] [Abstract][Full Text] [Related]
19. Profiling of serum metabolites in canine lymphoma using gas chromatography mass spectrometry.
Tamai R; Furuya M; Hatoya S; Akiyoshi H; Yamamoto R; Komori Y; Yokoi S; Tani K; Hirano Y; Komori M; Takenaka S
J Vet Med Sci; 2014 Nov; 76(11):1513-8. PubMed ID: 25131950
[TBL] [Abstract][Full Text] [Related]
20. Principles of treatment for canine lymphoma.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):92-7. PubMed ID: 12831068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
